List of Clinical Trial Summaries

※Listed in order of date of first publication

Medical Condition Phase Project Code Country Recruitment Status Access to Trial ID
Central Retinal Artery Occlusion 3 SJP-0008 Japan Recruiting jRCT2011230042
Primary Open Angle Glaucoma or
Ocular Hypertension		 3 SJP-0135 Japan Active,
not Recruiting		 jRCT2031230312
Dry Eye Disease 3 SJP-0132 Japan Active,
not Recruiting		 jRCT2031220497
Dry Eye Disease 3 SJP-0132 Japan Active,
not Recruiting		 jRCT2031220392
Meibomian Gland Dysfunction 2 KRP-KC121E Japan Completed jRCT2031220407
Healthy Volunteers 1 SJP-0008 United Kingdom Completed NCT05320861
Healthy Volunteers 1 SJP-0008 Japan Completed jRCT2031210444
Healthy Volunteers 1 SJP-0008 Japan Completed jRCT2031210280
Dry Eye Disease 2 SJP-0132 Japan Completed jRCT2031200243
Dry Eye Disease 1/2 SJP-0132 United States Completed NCT04139122

Disclaimer

This website provides information on clinical trials sponsored by SENJU PHARMACEUTICAL Co., Ltd. (hereinafter referred to as “SENJU”) to the public including patients and their families, in order to ensure the transparency of clinical trials.
This information on this website is not intended to advertise or promote SENJU ’s products, or to recruit participants.
Participants in a clinical trial are enrolled at the discretion of a physician after having a detailed explanation and test at the medical institution where a clinical trial is conducted.
Only a physician experienced in treating the specific disease can determine if a specific medicine used in a clinical trial is the correct treatment for a particular patient. If you have questions regarding specific symptoms or treatments, please consult a physician.
Clinical trial information posted on this website is prepared within the scope of the information registered with Japan Registry of Clinical Trials (jRCT), ClinicalTrials.gov, and EU Clinical Trials Register (EU-CTR).
SENJU makes every effort to update any changes to the information posted on this website. However, please note that the information may differ from the up-to-date information depending on when it is updated.

Disclaimer

This website provides information on clinical trials sponsored by SENJU PHARMACEUTICAL Co., Ltd. (hereinafter referred to as “SENJU”) to the public including patients and their families, in order to ensure the transparency of clinical trials.
This information on this website is not intended to advertise or promote SENJU ’s products, or to recruit participants.
Participants in a clinical trial are enrolled at the discretion of a physician after having a detailed explanation and test at the medical institution where a clinical trial is conducted.
Only a physician experienced in treating the specific disease can determine if a specific medicine used in a clinical trial is the correct treatment for a particular patient. If you have questions regarding specific symptoms or treatments, please consult a physician.
Clinical trial information posted on this website is prepared within the scope of the information registered with Japan Registry of Clinical Trials (jRCT), ClinicalTrials.gov, and EU Clinical Trials Register (EU-CTR).
SENJU makes every effort to update any changes to the information posted on this website. However, please note that the information may differ from the up-to-date information depending on when it is updated.